David Saxon
Stock Analyst at Needham
(1.32)
# 3,586
Out of 4,564 analysts
491
Total ratings
35%
Success rate
-0.3%
Average return
Main Sectors:
Stocks Rated by David Saxon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintained: Hold | n/a | $24.19 | - | 37 | Jul 17, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $255 | $107.67 | +136.83% | 42 | Jul 16, 2026 | |
| RXST RxSight | Maintained: Buy | $11 | $5.37 | +104.84% | 39 | Jul 7, 2026 | |
| CARL Carlsmed | Initiated Coverage: Buy | $17 | $11.00 | +54.55% | 1 | Jul 1, 2026 | |
| GKOS Glaukos | Maintained: Buy | $136 → $150 | $152.13 | -1.40% | 27 | Jun 17, 2026 | |
| COO The Cooper Companies | Rated: Buy | $101 → $86 | $70.23 | +22.45% | 27 | Jun 5, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $27 | $16.47 | +63.93% | 49 | Jun 3, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $114 → $117 | $75.42 | +55.13% | 28 | May 8, 2026 | |
| NVST Envista Holdings | Maintained: Hold | $27 | $26.17 | +3.17% | 17 | May 7, 2026 | |
| SGHT Sight Sciences | Maintained: Hold | n/a | $4.70 | - | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $14 | $8.21 | +70.52% | 39 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $33 | $28.30 | +16.61% | 40 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $12.72 | - | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 81.31 → CHF 77.24 | CHF 54.70 | +41.21% | 37 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $15 | $16.03 | -6.43% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $184 | $168.24 | +9.37% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.98 | - | 17 | Apr 29, 2026 |
STAAR Surgical Company
Jul 17, 2026
Maintained: Hold
Price Target: n/a
Current: $24.19
Upside: -
iRhythm Holdings
Jul 16, 2026
Reiterated: Buy
Price Target: $255
Current: $107.67
Upside: +136.83%
RxSight
Jul 7, 2026
Maintained: Buy
Price Target: $11
Current: $5.37
Upside: +104.84%
Carlsmed
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $11.00
Upside: +54.55%
Glaukos
Jun 17, 2026
Maintained: Buy
Price Target: $136 → $150
Current: $152.13
Upside: -1.40%
The Cooper Companies
Jun 5, 2026
Rated: Buy
Price Target: $101 → $86
Current: $70.23
Upside: +22.45%
SI-BONE
Jun 3, 2026
Reiterated: Buy
Price Target: $27
Current: $16.47
Upside: +63.93%
Globus Medical
May 8, 2026
Reiterated: Buy
Price Target: $114 → $117
Current: $75.42
Upside: +55.13%
Envista Holdings
May 7, 2026
Maintained: Hold
Price Target: $27
Current: $26.17
Upside: +3.17%
Sight Sciences
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $4.70
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $25 → $14
Current: $8.21
Upside: +70.52%
May 6, 2026
Reiterated: Buy
Price Target: $44 → $33
Current: $28.30
Upside: +16.61%
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $12.72
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: CHF 81.31 → CHF 77.24
Current: CHF 54.70
Upside: +41.21%
May 5, 2026
Rated: Buy
Price Target: $13 → $15
Current: $16.03
Upside: -6.43%
Apr 30, 2026
Maintained: Hold
Price Target: $184
Current: $168.24
Upside: +9.37%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $15.98
Upside: -